Industry evening mini symposium
Targeted Lung Denervation (TLD)- A One-Time Treatment for COPD and Severe Asthma
Organized by : Nuvaira
Chairs
A. Agusti Garcia-Navarro
Barcelona
(Spain)
F. Herth
Heidelberg
(Germany)
17:30
Welcome and Introduction
A. Agusti Garcia-Navarro (Barcelona, Spain)F. Herth (Heidelberg, Germany)
1
3473
17:35
Neural Control of Airway Smooth Muscle and Mucus Production
B. Canning (Baltimore, United States)
2
3474
17:45
Mechanism of Action and the NuvairaTM Lung Denervation System
P. Shah (London, United Kingdom)
3
3475
18:00
TLD in COPD: Data from the AIRFLOW-1 and Sham-Controlled AIRFLOW-2 Trials
D. Slebos (Groningen, Netherlands)A. Valipour (Wien, Austria)
4
3476
18:30
TLD in COPD: The AIRFLOW-3 Pivotal Trial
F. Sciurba (Pittsburgh, United States)
5
3477
18:40
TLD in Severe Asthma
P. Shah (London, United Kingdom)
6
3478
18:45
Panel Discussion and Q&A
8
3479
. . .
